{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T11:03:13Z","timestamp":1792839793088,"version":"4.5.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2020,9,8]],"date-time":"2020-09-08T00:00:00Z","timestamp":1599523200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,9,8]],"date-time":"2020-09-08T00:00:00Z","timestamp":1599523200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2021,3]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Liver transplantation (LT) has been performed in a select group of patients presenting with unresectable or primary sclerosing cholangitis (PSC)-associated perihilar cholangiocarcinoma (pCCA) in the Mayo Clinic with a reported 5-year overall survival (OS) of 53% on intention-to-treat analysis. The objective of this study was to estimate eligibility for LT in a cohort of pCCA patients in two tertiary referral centers.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Patients diagnosed with pCCA between 2002 and 2014 were included from two tertiary referral centers in the Netherlands. The selection criteria used by the Mayo Clinic were retrospectively applied to determine the proportion of patients that would have been eligible for LT.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 732 consecutive patients with pCCA were identified, of whom 24 (4%) had PSC-associated pCCA. Overall, 154 patients had resectable disease on imaging and 335 patients were ineligible for LT because of lymph node or distant metastases. An age limit of 70\u00a0years led to the exclusion of 50 patients who would otherwise be eligible for LT. After applying the Mayo Clinic criteria, only 34 patients (5%) were potentially eligible for LT. Median survival from diagnosis for these 34 patients was 13\u00a0months (95% CI 3\u201323).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Only 5% of all patients presenting with pCCA were potentially eligible for LT under the Mayo criteria. Without transplantation, a median OS of about 1\u00a0year was observed.<\/jats:p><\/jats:sec>","DOI":"10.1245\/s10434-020-09001-8","type":"journal-article","created":{"date-parts":[[2020,9,10]],"date-time":"2020-09-10T08:18:53Z","timestamp":1599725933000},"page":"1483-1492","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["Eligibility for Liver Transplantation in Patients with Perihilar Cholangiocarcinoma"],"prefix":"10.1245","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8411-0829","authenticated-orcid":false,"given":"Jaynee J. A.","family":"Vugts","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcia P.","family":"Gaspersz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Roos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lotte C.","family":"Franken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pim B.","family":"Olthof","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J. S.","family":"Coelen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeroen L. A.","family":"van Vugt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim A.","family":"Labeur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lieke","family":"Brouwer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc G. H.","family":"Besselink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan N. M.","family":"IJzermans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarwa","family":"Darwish Murad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas M.","family":"van Gulik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeroen","family":"de Jonge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wojciech G.","family":"Polak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier R. C.","family":"Busch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joris L.","family":"Erdmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bas","family":"Groot Koerkamp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Buettner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,9,8]]},"reference":[{"issue":"4","key":"9001_CR1","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1080\/13651820500372533","volume":"7","author":"W Jarnagin","year":"2005","unstructured":"Jarnagin W, Winston C. Hilar cholangiocarcinoma: diagnosis and staging. HPB (Oxford). 2005;7(4):244\u201351.","journal-title":"HPB (Oxford)"},{"key":"9001_CR2","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-40618-3","volume-title":"AJCC cancer staging manual","author":"MB Amin","year":"2017","unstructured":"Amin MB, Edge SB, American Joint Committee on C. AJCC cancer staging manual. 8 ed. Bern: Springer; 2017.","edition":"8"},{"issue":"2","key":"9001_CR3","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.suc.2015.12.008","volume":"96","author":"H Hartog","year":"2016","unstructured":"Hartog H, Ijzermans JN, van Gulik TM, Groot Koerkamp B. Resection of perihilar cholangiocarcinoma. Surg Clin North Am. 2016;96(2):247\u201367.","journal-title":"Surg Clin North Am"},{"issue":"9","key":"9001_CR4","doi-asserted-by":"publisher","first-page":"1930","DOI":"10.1093\/annonc\/mdv279","volume":"26","author":"B Groot Koerkamp","year":"2015","unstructured":"Groot Koerkamp B, Wiggers JK, Gonen M, Doussot A, Allen PJ, Besselink MG, et al. Survival after resection of perihilar cholangiocarcinoma\u2014development and external validation of a prognostic nomogram. Ann Oncol. 2015;26(9):1930\u20135.","journal-title":"Ann Oncol"},{"issue":"6","key":"9001_CR5","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1007\/s00423-014-1210-x","volume":"399","author":"I Popescu","year":"2014","unstructured":"Popescu I, Dumitrascu T. Curative-intent surgery for hilar cholangiocarcinoma: prognostic factors for clinical decision making. Langenbecks Arch Surg. 2014;399(6):693\u2013705.","journal-title":"Langenbecks Arch Surg"},{"issue":"4","key":"9001_CR6","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1097\/00000658-200110000-00010","volume":"234","author":"WR Jarnagin","year":"2001","unstructured":"Jarnagin WR, Fong Y, DeMatteo RP, Gonen M, Burke EC, Bodniewicz BJ, et al. Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma. Ann Surg. 2001;234(4):507\u201317; discussion 17-9.","journal-title":"Ann Surg"},{"issue":"12","key":"9001_CR7","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1038\/ajg.2014.327","volume":"109","author":"R Chaiteerakij","year":"2014","unstructured":"Chaiteerakij R, Harmsen WS, Marrero CR, Aboelsoud MM, Ndzengue A, Kaiya J, et al. A new clinically based staging system for perihilar cholangiocarcinoma. Am J Gastroenterol. 2014;109(12):1881\u201390.","journal-title":"Am J Gastroenterol"},{"issue":"14","key":"9001_CR8","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1056\/NEJMoa0908721","volume":"362","author":"J Valle","year":"2010","unstructured":"Valle J, Wasan H, Palmer DH, Cunningham D, Anthoney A, Maraveyas A, et al. Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer. N Engl J Med. 2010;362(14):1273\u201381.","journal-title":"N Engl J Med"},{"issue":"4","key":"9001_CR9","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1586\/egh.12.20","volume":"6","author":"V Valero 3rd","year":"2012","unstructured":"Valero V, 3rd, Cosgrove D, Herman JM, Pawlik TM. Management of perihilar cholangiocarcinoma in the era of multimodal therapy. Expert Rev Gastroenterol Hepatol. 2012;6(4):481\u201395.","journal-title":"Expert Rev Gastroenterol Hepatol"},{"issue":"3","key":"9001_CR10","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.jamcollsurg.2012.05.025","volume":"215","author":"K Matsuo","year":"2012","unstructured":"Matsuo K, Rocha FG, Ito K, D\u2019Angelica MI, Allen PJ, Fong Y, et al. The Blumgart preoperative staging system for hilar cholangiocarcinoma: analysis of resectability and outcomes in 380 patients. J Am Coll Surg. 2012;215(3):343\u201355.","journal-title":"J Am Coll Surg"},{"issue":"8","key":"9001_CR11","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1007\/s11605-016-3155-6","volume":"20","author":"S Buettner","year":"2016","unstructured":"Buettner S, Wilson A, Margonis GA, Gani F, Ethun CG, Poultsides GA, et al. Assessing trends in palliative surgery for extrahepatic biliary malignancies: a 15-year multicenter study. J Gastrointest Surg. 2016;20(8):1444\u201352.","journal-title":"J Gastrointest Surg"},{"issue":"2","key":"9001_CR12","doi-asserted-by":"publisher","first-page":"321\u201331.e1","DOI":"10.1016\/j.jamcollsurg.2016.03.035","volume":"223","author":"JK Wiggers","year":"2016","unstructured":"Wiggers JK, Groot Koerkamp B, Cieslak KP, Doussot A, van Klaveren D, Allen PJ, et al. Postoperative mortality after liver resection for perihilar cholangiocarcinoma: development of a risk score and importance of biliary drainage of the future liver remnant. J Am Coll Surg. 2016;223(2):321\u201331.e1.","journal-title":"J Am Coll Surg"},{"issue":"1","key":"9001_CR13","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1097\/SLA.0b013e3182708b57","volume":"258","author":"M Nagino","year":"2013","unstructured":"Nagino M, Ebata T, Yokoyama Y, Igami T, Sugawara G, Takahashi Y, et al. Evolution of surgical treatment for perihilar cholangiocarcinoma: a single-center 34-year review of 574 consecutive resections. Ann Surg. 2013;258(1):129\u201340.","journal-title":"Ann Surg"},{"issue":"1","key":"9001_CR14","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1001\/archsurg.2011.771","volume":"147","author":"G Nuzzo","year":"2012","unstructured":"Nuzzo G, Giuliante F, Ardito F, Giovannini I, Aldrighetti L, Belli G, et al. Improvement in perioperative and long-term outcome after surgical treatment of hilar cholangiocarcinoma: results of an Italian multicenter analysis of 440 patients. Arch Surg. 2012;147(1):26\u201334.","journal-title":"Arch Surg"},{"issue":"1","key":"9001_CR15","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1177\/000313481307900136","volume":"79","author":"GM Kaiser","year":"2013","unstructured":"Kaiser GM, Paul A, Sgourakis G, Molmenti EP, Dechene A, Trarbach T, et al. Novel prognostic scoring system after surgery for Klatskin tumor. Am Surg. 2013;79(1):90\u20135.","journal-title":"Am Surg"},{"issue":"3","key":"9001_CR16","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1002\/jso.25174","volume":"118","author":"MP Gaspersz","year":"2018","unstructured":"Gaspersz MP, Buettner S, Roos E, Vugt JLA, Coelen RJS, Vugts J, et al. A preoperative prognostic model to predict surgical success in patients with perihilar cholangiocarcinoma. J Surg Oncol. 2018;118(3):469\u201376.","journal-title":"J Surg Oncol"},{"issue":"6","key":"9001_CR17","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.1007\/s00268-015-2988-6","volume":"39","author":"H Otsuji","year":"2015","unstructured":"Otsuji H, Yokoyama Y, Ebata T, Igami T, Sugawara G, Mizuno T, et al. Preoperative sarcopenia negatively impacts postoperative outcomes following major hepatectomy with extrahepatic bile duct resection. World J Surg. 2015;39(6):1494\u2013500.","journal-title":"World J Surg"},{"issue":"2","key":"9001_CR18","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1159\/000486867","volume":"36","author":"JLA van Vugt","year":"2019","unstructured":"van Vugt JLA, Gaspersz MP, Vugts J, Buettner S, Levolger S, de Bruin RWF, et al. Low skeletal muscle density is associated with early death in patients with perihilar cholangiocarcinoma regardless of subsequent treatment. Dig Surg. 2019;36(2):144\u201352.","journal-title":"Dig Surg"},{"issue":"7","key":"9001_CR19","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1111\/j.1432-2277.2010.01108.x","volume":"23","author":"CB Rosen","year":"2010","unstructured":"Rosen CB, Heimbach JK, Gores GJ. Liver transplantation for cholangiocarcinoma. Transpl Int. 2010;23(7):692\u20137.","journal-title":"Transpl Int"},{"issue":"1","key":"9001_CR20","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1053\/j.gastro.2012.04.008","volume":"143","author":"S Darwish Murad","year":"2012","unstructured":"Darwish Murad S, Kim WR, Harnois DM, Douglas DD, Burton J, Kulik LM, et al. Efficacy of neoadjuvant chemoradiation, followed by liver transplantation, for perihilar cholangiocarcinoma at 12 US centers. Gastroenterology. 2012;143(1):88\u201398.e3; quiz e14.","journal-title":"Gastroenterology"},{"issue":"2","key":"9001_CR21","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1055\/s-2004-828896","volume":"24","author":"JK Heimbach","year":"2004","unstructured":"Heimbach JK, Gores GJ, Haddock MG, Alberts SR, Nyberg SL, Ishitani MB, et al. Liver transplantation for unresectable perihilar cholangiocarcinoma. Semin Liver Dis. 2004;24(2):201\u20137.","journal-title":"Semin Liver Dis"},{"issue":"3","key":"9001_CR22","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1002\/hep.25629","volume":"56","author":"S Darwish Murad","year":"2012","unstructured":"Darwish Murad S, Kim WR, Therneau T, Gores GJ, Rosen CB, Martenson JA, et al. Predictors of pretransplant dropout and posttransplant recurrence in patients with perihilar cholangiocarcinoma. Hepatology. 2012;56(3):972\u201381.","journal-title":"Hepatology"},{"issue":"1","key":"9001_CR23","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.jamcollsurg.2012.03.014","volume":"215","author":"CB Rosen","year":"2012","unstructured":"Rosen CB, Darwish Murad S, Heimbach JK, Nyberg SL, Nagorney DM, Gores GJ. Neoadjuvant therapy and liver transplantation for hilar cholangiocarcinoma: is pretreatment pathological confirmation of diagnosis necessary? J Am Coll Surg. 2012;215(1):31\u20138; discussion 8-40.","journal-title":"J Am Coll Surg"},{"issue":"1","key":"9001_CR24","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.hpb.2017.08.025","volume":"20","author":"JLA van Vugt","year":"2018","unstructured":"van Vugt JLA, Gaspersz MP, Coelen RJS, Vugts J, Labeur TA, de Jonge J, et al. The prognostic value of portal vein and hepatic artery involvement in patients with perihilar cholangiocarcinoma. HPB (Oxford). 2018;20(1):83\u201392.","journal-title":"HPB (Oxford)"},{"key":"9001_CR25","volume-title":"National guideline biliary tract carcinoma","author":"Dutch Cancer Institute","year":"2013","unstructured":"Dutch Cancer Institute. National guideline biliary tract carcinoma. Amsterdam: Dutch Cancer Institute; 2013."},{"issue":"3","key":"9001_CR26","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1097\/01.sla.0000179678.13285.fa","volume":"242","author":"DJ Rea","year":"2005","unstructured":"Rea DJ, Heimbach JK, Rosen CB, Haddock MG, Alberts SR, Kremers WK, et al. Liver transplantation with neoadjuvant chemoradiation is more effective than resection for hilar cholangiocarcinoma. Ann Surg. 2005;242(3):451\u20138; discussion 8-61.","journal-title":"Ann Surg"},{"issue":"11","key":"9001_CR27","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1016\/j.hpb.2017.07.004","volume":"19","author":"MP Gaspersz","year":"2017","unstructured":"Gaspersz MP, Buettner S, van Vugt JLA, Roos E, Coelen RJS, Vugts J, et al. Conditional survival in patients with unresectable perihilar cholangiocarcinoma. HPB. 2017;19(11):966\u201371.","journal-title":"HPB"},{"issue":"9","key":"9001_CR28","doi-asserted-by":"publisher","first-page":"2179","DOI":"10.1007\/s00268-012-1638-5","volume":"36","author":"AT Ruys","year":"2012","unstructured":"Ruys AT, van Haelst S, Busch OR, Rauws EA, Gouma DJ, van Gulik TM. Long-term survival in hilar cholangiocarcinoma also possible in unresectable patients. World J Surg. 2012;36(9):2179\u201386.","journal-title":"World J Surg"},{"issue":"6","key":"9001_CR29","doi-asserted-by":"publisher","first-page":"e0156127","DOI":"10.1371\/journal.pone.0156127","volume":"11","author":"HT Mantel","year":"2016","unstructured":"Mantel HT, Westerkamp AC, Adam R, Bennet WF, Seehofer D, Settmacher U, et al. Strict selection alone of patients undergoing liver transplantation for hilar cholangiocarcinoma is associated with improved survival. PloS ONE. 2016;11(6):e0156127.","journal-title":"PLoS ONE"},{"issue":"1","key":"9001_CR30","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1097\/00000658-199101000-00004","volume":"213","author":"CB Rosen","year":"1991","unstructured":"Rosen CB, Nagorney DM, Wiesner RH, Coffey RJ, Jr., LaRusso NF. Cholangiocarcinoma complicating primary sclerosing cholangitis. Ann Surg. 1991;213(1):21\u20135.","journal-title":"Ann Surg"},{"issue":"9935","key":"9001_CR31","doi-asserted-by":"publisher","first-page":"2168","DOI":"10.1016\/S0140-6736(13)61903-0","volume":"383","author":"N Razumilava","year":"2014","unstructured":"Razumilava N, Gores GJ. Cholangiocarcinoma. Lancet. 2014;383(9935):2168\u201379.","journal-title":"Lancet"},{"issue":"1","key":"9001_CR32","first-page":"42","volume":"31","author":"MC Bragazzi","year":"2018","unstructured":"Bragazzi MC, Ridola L, Safarikia S, Matteo SD, Costantini D, Nevi L, et al. New insights into cholangiocarcinoma: multiple stems and related cell lineages of origin. Ann Gastroenterol. 2018;31(1):42\u201355.","journal-title":"Ann Gastroenterol"},{"issue":"6","key":"9001_CR33","doi-asserted-by":"publisher","first-page":"780","DOI":"10.2353\/jmoldx.2010.100016","volume":"12","author":"BR Kipp","year":"2010","unstructured":"Kipp BR, Fritcher EG, Clayton AC, Gores GJ, Roberts LR, Zhang J, et al. Comparison of KRAS mutation analysis and FISH for detecting pancreatobiliary tract cancer in cytology specimens collected during endoscopic retrograde cholangiopancreatography. J Mol Diagn. 2010;12(6):780\u20136.","journal-title":"J Mol Diagn"},{"issue":"2","key":"9001_CR34","doi-asserted-by":"publisher","first-page":"23","DOI":"10.4291\/wjgp.v1.i2.23","volume":"1","author":"L Huang","year":"2010","unstructured":"Huang L, Frampton G, Liang LJ, Demorrow S. Aberrant DNA methylation profile in cholangiocarcinoma. World J Gastrointest Pathophysiol. 2010;1(2):23\u20139.","journal-title":"World J Gastrointest Pathophysiol"},{"issue":"11","key":"9001_CR35","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1016\/S0025-6196(11)60667-8","volume":"84","author":"JF Aduen","year":"2009","unstructured":"Aduen JF, Sujay B, Dickson RC, Heckman MG, Hewitt WR, Stapelfeldt WH, et al. Outcomes after liver transplant in patients aged 70\u00a0years or older compared with those younger than 60\u00a0years. Mayo Clin Proc. 2009;84(11):973\u20138.","journal-title":"Mayo Clin Proc"},{"issue":"21","key":"9001_CR36","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1056\/NEJM199005243222106","volume":"322","author":"RW Strong","year":"1990","unstructured":"Strong RW, Lynch SV, Ong TH, Matsunami H, Koido Y, Balderson GA. Successful liver transplantation from a living donor to her son. N Engl J Med. 1990;322(21):1505\u20137.","journal-title":"N Engl J Med"},{"issue":"2","key":"9001_CR37","first-page":"159","volume":"5","author":"S Nadalin","year":"2016","unstructured":"Nadalin S, Capobianco I, Panaro F, Di Francesco F, Troisi R, Sainz-Barriga M, et al. Living donor liver transplantation in Europe. Hepatobiliary Surg Nutr. 2016;5(2):159\u201375.","journal-title":"Hepatobiliary Surg Nutr"},{"issue":"9","key":"9001_CR38","doi-asserted-by":"publisher","first-page":"3185","DOI":"10.1016\/j.transproceed.2008.08.036","volume":"40","author":"I Fouzas","year":"2008","unstructured":"Fouzas I, Sotiropoulos GC, Lang H, Nadalin S, Beckebaum S, Sgourakis G, et al. Living donor liver transplantation for hepatocellular carcinoma in patients exceeding the UCSF criteria. Transplant Proc. 2008;40(9):3185\u20138.","journal-title":"Transplant Proc"},{"issue":"4","key":"9001_CR39","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/j.jhep.2018.12.009","volume":"70","author":"F Durand","year":"2019","unstructured":"Durand F, Levitsky J, Cauchy F, Gilgenkrantz H, Soubrane O, Francoz C. Age and liver transplantation. J Hepatol. 2019;70(4):745\u201358.","journal-title":"J Hepatol"},{"issue":"4","key":"9001_CR40","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1159\/000446382","volume":"32","author":"M Lauerer","year":"2016","unstructured":"Lauerer M, Kaiser K, Nagel E. Organ transplantation in the face of donor shortage\u2014ethical implications with a focus on liver allocation. Visc Med. 2016;32(4):278\u201385.","journal-title":"Visc Med"},{"key":"9001_CR41","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1159\/000382063","volume":"83","author":"T Cederholm","year":"2015","unstructured":"Cederholm T. Overlaps between frailty and sarcopenia definitions. Nestle Nutr Inst Workshop Ser. 2015;83:65\u20139.","journal-title":"Nestle Nutr Inst Workshop Ser"},{"issue":"2","key":"9001_CR42","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/s11938-018-0179-x","volume":"16","author":"B Kok","year":"2018","unstructured":"Kok B, Tandon P. Frailty in patients with cirrhosis. Curr Treat Options Gastroenterol. 2018;16(2):215\u201325.","journal-title":"Curr Treat Options Gastroenterol"},{"issue":"8","key":"9001_CR43","doi-asserted-by":"publisher","first-page":"2277","DOI":"10.1111\/ajt.13732","volume":"16","author":"JL van Vugt","year":"2016","unstructured":"van Vugt JL, Levolger S, de Bruin RW, van Rosmalen J, Metselaar HJ, IJzermans JN. Systematic review and meta-analysis of the impact of computed tomography-assessed skeletal muscle mass on outcome in patients awaiting or undergoing liver transplantation. Am J Transplant. 2016;16(8):2277\u201392.","journal-title":"Am J Transplant."},{"issue":"11","key":"9001_CR44","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1111\/ctr.12808","volume":"30","author":"NH Dolgin","year":"2016","unstructured":"Dolgin NH, Martins PN, Movahedi B, Lapane KL, Anderson FA, Bozorgzadeh A. Functional status predicts postoperative mortality after liver transplantation. Clin Transplant. 2016;30(11):1403\u201310.","journal-title":"Clin Transplant."},{"issue":"12","key":"9001_CR45","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1111\/ctr.12629","volume":"29","author":"PW Underwood","year":"2015","unstructured":"Underwood PW, Cron DC, Terjimanian MN, Wang SC, Englesbe MJ, Waits SA. Sarcopenia and failure to rescue following liver transplantation. Clin Transplant. 2015;29(12):1076\u201380.","journal-title":"Clin Transplant"},{"key":"9001_CR46","doi-asserted-by":"crossref","unstructured":"van Vugt JLA, Alferink LJM, Buettner S, Gaspersz MP, Bot D, Darwish Murad S, et al. A model including sarcopenia surpasses the MELD score in predicting waiting list mortality in cirrhotic liver transplant candidates: A competing risk analysis in a national cohort. J Hepatol. 2018;68(4):707\u201314.","DOI":"10.1016\/j.jhep.2017.11.030"},{"issue":"2","key":"9001_CR47","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1053\/j.gastro.2015.10.043","volume":"150","author":"F Su","year":"2016","unstructured":"Su F, Yu L, Berry K, Liou IW, Landis CS, Rayhill SC, et al. Aging of liver transplant registrants and recipients: trends and impact on waitlist outcomes, post-transplantation outcomes, and transplant-related survival benefit. Gastroenterology. 2016;150(2):441-53.e6.","journal-title":"Gastroenterology."},{"issue":"12","key":"9001_CR48","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1111\/hpb.12312","volume":"16","author":"GC Wilson","year":"2014","unstructured":"Wilson GC, Quillin RC, 3rd, Wima K, Sutton JM, Hoehn RS, Hanseman DJ, et al. Is liver transplantation safe and effective in elderly (\u2265\u200970\u00a0years) recipients? A case-controlled analysis. HPB Off J Int Hepato Pancreato Biliary Assoc. 2014;16(12):1088\u201394.","journal-title":"HPB Off J Int Hepato Pancreato Biliary Assoc"},{"issue":"1","key":"9001_CR49","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.hpb.2018.07.025","volume":"21","author":"C Gomez Gavara","year":"2019","unstructured":"Gomez Gavara C, Esposito F, Gurusamy K, Salloum C, Lahat E, Feray C, et al. Liver transplantation in elderly patients: a systematic review and first meta-analysis. HPB (Oxford). 2019;21(1):14\u201325.","journal-title":"HPB (Oxford)"},{"issue":"4","key":"9001_CR50","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1016\/S0016-5107(02)70442-2","volume":"56","author":"M De Bellis","year":"2002","unstructured":"De Bellis M, Sherman S, Fogel EL, Cramer H, Chappo J, McHenry L, Jr., et al. Tissue sampling at ERCP in suspected malignant biliary strictures (part 1). Gastrointest Endosc. 2002;56(4):552\u201361.","journal-title":"Gastrointest Endosc"}],"updated-by":[{"DOI":"10.1245\/s10434-021-10171-2","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2021,5,20]],"date-time":"2021-05-20T00:00:00Z","timestamp":1621468800000}}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-020-09001-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-020-09001-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-020-09001-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,7]],"date-time":"2023-10-07T03:51:08Z","timestamp":1696650668000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-020-09001-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,8]]},"references-count":50,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["9001"],"URL":"https:\/\/doi.org\/10.1245\/s10434-020-09001-8","relation":{"correction":[{"id-type":"doi","id":"10.1245\/s10434-021-10171-2","asserted-by":"object"}]},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,8]]},"assertion":[{"value":"18 March 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 September 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2021","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1245\/s10434-021-10171-2","URL":"https:\/\/doi.org\/10.1245\/s10434-021-10171-2","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"None.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}}]}}